Saying that you're going to quit smoking is easy. What's harder is not lighting up over the long term and, ideally, forever. That's why smokers struggle with quitting. It takes an average of five ...

The purpose of this study was to investigate whether smokers prepared to control their smoking, but not necessarily prepared to quit smoking, could reduce or quit with a choice of one of two NRT ...

Despite the growing evidence of the limitations of NRT in “real-world” situations, pharmaceutical patches, inhalers and gums continue to play a key role in smoking cessation policy.

- RespiRx™ Nicotine Inhaler is the world's first truly inhalable nicotine replacement therapy - - Clinical data from Phase 1 study for RespiRx™ Nicotine Inhaler in U.S. expected in Q2 2025 – ...

Pune, Sept. 13, 2024 (GLOBE NEWSWIRE) -- According to New Research Report “Nicotine Replacement Therapy Market Size, Share Analysis By Type (Gums, Patches, Lozenges, Inhalers, and Others), By ...

The use of nicotine patches, gum, lozenges, inhalers or nasal sprays – together called “nicotine replacement therapy,” or NRT – came into play in 1984 as prescription medicine, which when combined ...

As Covid-19 adds urgency to smokers’ attempts to quit, a U.S. startup says it has a new way to help them kick the habit. Respira Technologies Inc. plans to submit an inhaler device to the Food ...

-The study will evaluate the pharmacokinetics, safety and tolerability of the RespiRx ™ Nicotine Inhaler compared to Nicotrol ® Inhaler and combustible cigarettes - RICHMOND, Va., Oct. 1, 2024 ...

Chrono is not the only company experimenting with smoking-cessation methods. In 2012, CN Creative secured $3.1 million in financing to develop its electronic inhaler NRT device to help patients ...

This was a double-blind, placebo-controlled trial with parallel groups, performed at two medical centers (Prague and Kutná Hora) in the Czech Republic. Two NRT products were used, nicotine 10 mg ...